Your browser doesn't support javascript.
loading
Trajectories of alcohol consumption during life and the risk of developing breast cancer.
Donat-Vargas, Carolina; Guerrero-Zotano, Ángel; Casas, Ana; Baena-Cañada, José Manuel; Lope, Virginia; Antolín, Silvia; Garcia-Saénz, José Ángel; Bermejo, Begoña; Muñoz, Montserrat; Ramos, Manuel; de Juan, Ana; Jara Sánchez, Carlos; Sánchez-Rovira, Pedro; Antón, Antonio; Brunet, Joan; Gavilá, Joaquín; Salvador, Javier; Arriola Arellano, Esperanza; Bezares, Susana; Fernández de Larrea-Baz, Nerea; Pérez-Gómez, Beatriz; Martín, Miguel; Pollán, Marina.
Afiliación
  • Donat-Vargas C; IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain.
  • Guerrero-Zotano Á; Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid-IdiPaz, CIBERESP (CIBER of Epidemiology and Public Health), Madrid, Spain.
  • Casas A; Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Baena-Cañada JM; Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain.
  • Lope V; Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain.
  • Antolín S; Medical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain.
  • Garcia-Saénz JÁ; Instituto de Investigación en Biomedicina de Cádiz (INiBICA), Cádiz, Spain.
  • Bermejo B; National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain.
  • Muñoz M; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
  • Ramos M; Medical Oncology Unit, Complejo Hospitalario Universitario, A Coruña, Spain.
  • de Juan A; Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain.
  • Jara Sánchez C; Medical Oncology Unit, Hospital Clínico, Valencia, Spain.
  • Sánchez-Rovira P; Medical Oncology Unit, Hospital Clinic i Provincial, Barcelona, Spain.
  • Antón A; Translational Genomics and Targeted Therapeutics, Institut d'Investigacions Biomèdiques Pi i Sunyer-IDIBAPS, Barcelona, Spain.
  • Brunet J; Medical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain.
  • Gavilá J; Medical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain.
  • Salvador J; Medical Oncology Unit/Departamento Especialidades Médicas, Hospital Universitario Fundación Alcorcón/Universidad Rey Juan Carlos, Madrid, Spain.
  • Arriola Arellano E; Medical Oncology Unit, Hospital Universitario de Jaén, Jaén, España.
  • Bezares S; Medical Oncology Unit, Hospital Universitario Miguel Servet, Zaragoza, España.
  • Fernández de Larrea-Baz N; Medical Oncology Department, Institut Català d'Oncologia, IDIBGi, Girona, Spain.
  • Pérez-Gómez B; Medical Sciences Department, Universitat de Girona, Girona, Spain.
  • Martín M; Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain.
  • Pollán M; Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain.
Br J Cancer ; 125(8): 1168-1176, 2021 10.
Article en En | MEDLINE | ID: mdl-34483338
BACKGROUND: Whether there are lifetime points of greater sensitivity to the deleterious effects of alcohol intake on the breasts remains inconclusive. OBJECTIVE: To compare the influence of distinctive trajectories of alcohol consumption throughout a woman's life on development of breast cancer (BC). METHODS: 1278 confirmed invasive BC cases and matched (by age and residence) controls from the Epi-GEICAM study (Spain) were used. The novel group-based trajectory modelling was used to identify different alcohol consumption trajectories throughout women's lifetime. RESULTS: Four alcohol trajectories were identified. The first comprised women (45%) with low alcohol consumption (<5 g/day) throughout their life. The second included those (33%) who gradually moved from a low alcohol consumption in adolescence to a moderate in adulthood (5 to <15 g/day), never having a high consumption; and oppositely, women in the third trajectory (16%) moved from moderate consumption in adolescence, to a lower consumption in adulthood. Women in the fourth (6%) moved from a moderate alcohol consumption in adolescence to the highest consumption in adulthood (≥15 g/day), never having a low alcohol consumption. Comparing with the first trajectory, the fourth doubled BC risk (OR 2.19; 95% CI 1.27, 3.77), followed by the third (OR 1.44; 0.96, 2.16) and ultimately by the second trajectory (OR 1.17; 0.86, 1.58). The magnitude of BC risk was greater in postmenopausal women, especially in those with underweight or normal weight. When alcohol consumption was independently examined at each life stage, ≥15 g/day of alcohol consumption in adolescence was strongly associated with BC risk followed by consumption in adulthood. CONCLUSIONS: The greater the alcohol consumption accumulated throughout life, the greater the risk of BC, especially in postmenopausal women. Alcohol consumption during adolescence may particularly influence BC risk.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Consumo de Bebidas Alcohólicas Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Br J Cancer Año: 2021 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Consumo de Bebidas Alcohólicas Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Br J Cancer Año: 2021 Tipo del documento: Article País de afiliación: España